Chinese children 結果共2筆

Chinese children are increasingly experiencing antibiotic resistance when treating Mycoplasma pneumoniae, which poses a global health and economic concern. By 2050, drug-resistant diseases could result in healthcare costs of NT＄31 trillion and economic losses of up to NT＄106 trillion, according to the World Bank. The overuse of antibiotics has led to the rise of superbugs, diminishing the effectiveness of these medicines and compromising treatment outcomes. Azithromycin, a commonly used antibiotic in China for Mycoplasma pneumoniae, now faces an alarming resistance rate of nearly 80% to Macrolides. The World Health Organization (WHO) warns of the dangers of antibiotic overuse and refers to the situation as a ＂silent pandemic.＂ WHO Director-General Tedros Adhanom Ghebreyesus expresses concern that antibiotic resistance could bring us back to an era where minor infections are untreatable.

The epidemic continues to spread in mainland China, and according to the Commander of the Central Epidemic Command Center, Victor Wang, their situation may reach its peak in 2 months. As many will be traveling back to Taiwan from the mainland for Chinese New Year, the CECC is urging children to get vaccinated or re-vaccinated.